Detalles de la búsqueda
1.
Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trial.
Int J Clin Oncol
; 25(2): 301-311, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31620931
2.
Pertuzumab Plus Trastuzumab for Treatment-Refractory HER2-Amplified Metastatic Colorectal Cancer: Comparison of the MyPathway Trial With a Real-World External Control Arm.
JCO Clin Cancer Inform
; 6: e2200022, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35649212
3.
Efficacy of trastuzumab emtansine in Japanese patients with previously treated HER2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma: A subgroup analysis of the GATSBY study.
Asia Pac J Clin Oncol
; 16(1): 5-13, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31721447
Resultados
1 -
3
de 3
1
Próxima >
>>